The second volume of this series features 7 reviews presenting updates on hormones and several classes of drugs:
-Osteocalcin action in glucose metabolism
-Sodium-glucose co-transporter 2 (SGLT2) inhibitors
-Glucagon-like peptide-1 (GLP-1) mimetics
-Dipeptidyl peptidase 4 (DPP-4) inhibitors
-New drugs in clinical trial and commercial phases
Loading...
Loading...

